Clinical Trials
Home Based Assessment (HBA)
  • A randomized, non-treatment study designed to find out more about information collection methods for Alzheimer's disease prevention studies.
  • This study is recruiting participants who:
    • Do not have a diagnosis of dementia
    • Are age 75 or older
    • Are independently-living adults
    • Have minimal computer skills or a willingness to learn
    • Are willing to take multi-vitamins twice a day as provided by the study.
  • This is a 4-year study. There are 18 visits, at least two of which will occur on the UC Irvine campus; the other 16 visits will occur at your home. Visits are every three months.
Nicotinamide (NA)
  • A double-blind, placebo-controlled 7-month study to find out more about Nicotinamide and its effects on Alzheimer's disease progression.
  • Nicotinamide (NA) is a class of drugs known as a HDAC inhibitor, a dietary supplement that is being studied to determine whether chronic use is safe and effective in improving brain function in subjects with mild to moderate Alzheimer's disease (AD).
  • This study is recruiting participants who:
    • Have a diagnosis of probable AD
    • Are 50 years of age or older
  • Have a study partner – friend or relative who can accompany the participant to all clinic visits and answer questions about him/her
    There are 7 total visits to the UC Irvine campus. Visits are every 2-6 weeks.

Click below for a printable version of our clinical trials flyers (PDF):

» Home Based Assessment (HBA) » Nicotinamide (NA)
HomeCalendar of EventsClinical ProgramsClinical TrialsEducation & TrainingResearch
Graduate & Post-Doctoral TrainingNewslettersAbout the InstituteSupport the InstituteFrequently Asked Questions